Stewart Goldman

  • 5852 Citations
1993 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research Interests

Developmental Therapeutics for Children with CNS cancers

Certifications and Licenses

Pediatric Hematology-Oncology

Training Experience

1986Internship, University of Chicago Hospitals
1988Residency, Univ. of Chicago Hospital
1991Fellowship, Univ. of Chicago Hospital

Education/Academic qualification

MD, Loyola University/Stritch School of Medicine

… → 1985

Research interests

  • Brain Cancer / Nervous System Cancer
  • Neuro-Oncology
  • Neurofibromatosis
  • Translational Research

Fingerprint Dive into the research topics where Stewart Goldman is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 8 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.


Research Output

Response assessment in paediatric high-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group

Erker, C., Tamrazi, B., Poussaint, T. Y., Mueller, S., Mata-Mbemba, D., Franceschi, E., Brandes, A. A., Rao, A., Haworth, K. B., Wen, P. Y., Goldman, S., Vezina, G., MacDonald, T. J., Dunkel, I. J., Morgan, P. S., Jaspan, T., Prados, M. D. & Warren, K. E., Jun 2020, In : The Lancet Oncology. 21, 6, p. e317-e329

Research output: Contribution to journalReview article

  • 1 Scopus citations

    Symptom burden trajectories experienced by patients with brain tumors

    Lai, J. S., Beaumont, J. L., Kupst, M. J., Peipert, J. D., Cella, D., Fisher, A. P. & Goldman, S., Jul 15 2020, In : Cancer. 126, 14, p. 3341-3351 11 p.

    Research output: Contribution to journalArticle

  • Improved neuropsychological outcomes following proton therapy relative to X-ray therapy for pediatric brain tumor patients

    Gross, J. P., Powell, S., Zelko, F., Hartsell, W., Goldman, S., Fangusaro, J., Lulla, R. R., Smiley, N. P., Chang, J. H. C. & Gondi, V., Jul 11 2019, In : Neuro-oncology. 21, 7, p. 934-943 10 p., noz070.

    Research output: Contribution to journalArticle

  • 10 Scopus citations

    Pharmacological mTOR targeting enhances the antineoplastic effects of selective PI3Kα inhibition in medulloblastoma

    Eckerdt, F., Clymer, J., Bell, J. B., Beauchamp, E. M., Blyth, G. T., Goldman, S. & Platanias, L. C., Dec 1 2019, In : Scientific reports. 9, 1, 12822.

    Research output: Contribution to journalArticle

    Open Access
  • 1 Scopus citations

    Phase I study of gene-mediated cytotoxic immunotherapy with AdV-tk as adjuvant to surgery and radiation for pediatric malignant glioma and recurrent ependymoma

    Kieran, M. W., Goumnerova, L., Manley, P., Chi, S. N., Marcus, K. J., Manzanera, A. G., Polanco, M. L. S., Guzik, B. W., Aguilar-Cordova, E., Diaz-Montero, C. M., Dipatri, A. J., Tomita, T., Lulla, R. R., Greenspan, L., Aguilar, L. K. & Goldman, S., Mar 18 2019, In : Neuro-oncology. 21, 4, p. 537-546 10 p.

    Research output: Contribution to journalArticle

  • 3 Scopus citations